| Summary of Computation of Company's Basic and Diluted Net (Loss) Income per Share |
The following table sets forth the computation of the Company’s basic and diluted net (loss) income per share.
|
|
|
Three Months Ended
|
|
|
Six Months Ended
|
|
|
|
|
June 30,
|
|
|
June 30,
|
|
|
|
|
2021
|
|
|
2020
|
|
|
2021
|
|
|
2020
|
|
|
|
|
(in thousands, except share and per share amounts)
|
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income, basic and diluted
|
|
$
|
(6,152
|
)
|
|
$
|
29,872
|
|
|
$
|
(36,511
|
)
|
|
$
|
10,277
|
|
|
Denominator:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares used to compute basic EPS
|
|
|
46,116,175
|
|
|
|
29,900,913
|
|
|
|
46,007,892
|
|
|
|
26,510,873
|
|
|
Dilutive effect of common stock options
|
|
|
–
|
|
|
|
1,020,799
|
|
|
|
–
|
|
|
|
1,124,799
|
|
|
Dilutive effect of restricted stock units
|
|
|
–
|
|
|
|
774,991
|
|
|
|
–
|
|
|
|
774,991
|
|
|
Dilutive effect of warrants to purchase common stock
|
|
|
–
|
|
|
|
81,257
|
|
|
|
–
|
|
|
|
127,616
|
|
|
Weighted-average shares used to compute diluted EPS
|
|
|
46,116,175
|
|
|
|
31,777,960
|
|
|
|
46,007,892
|
|
|
|
28,538,279
|
|
|
Net (loss) income per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.13
|
)
|
|
$
|
1.00
|
|
|
$
|
(0.79
|
)
|
|
$
|
0.39
|
|
|
Diluted
|
|
$
|
(0.13
|
)
|
|
$
|
0.94
|
|
|
$
|
(0.79
|
)
|
|
$
|
0.36
|
|
|
| Summary of Common Stock Equivalents of Antidilutive Securities Excluded from Computation of Diluted Net Loss per Share |
The following common stock equivalents were excluded from the computation of diluted net loss per share for
the periods ended June 30, 2021, because including them would have been antidilutive:
|
|
|
As of June 30,
|
|
|
|
|
2021
|
|
|
Common stock options issued and outstanding
|
|
|
6,250,931
|
|
|
Restricted stock units issued and outstanding
|
|
|
1,988,426
|
|
|
Warrants to purchase common stock
|
|
|
153,070
|
|
|
Employee stock purchase plan
|
|
|
36,902
|
|
|
Total
|
|
|
8,429,329
|
|
|